--:--:--
Stockwatch Reports
…

News Reports / Financial Services / LIFE

LIFEEthos Technologies Inc.

NasdaqGS · Financial Services · Mkt cap $2.8B · Avg vol 1.60M

$43.71

+1.09 (+2.56%)

Quote as of November 3, 2026, 12:37 PM ET

News Impact Report · Published November 3, 2026, 9:43 AM ET

LIFE: Ethos Technologies Reports Q2 FY2026 Results With $183.7M Revenue and $12.2M Net Income

Share

What Happened

Ethos Technologies Inc. (LIFE) filed an 8-K with the SEC on November 2, 2026, disclosing its financial results for the second quarter of fiscal year 2026 under Item 2.02 (Results of Operations and Financial Condition). The company reported quarterly revenue of $183.7 million, operating income of $31.4 million, and net income of $12.2 million. The filing is material because it provides the market's first official, auditor-reviewed look at the company's operational performance for the period.

Why It Matters

For investors, the headline numbers present a mixed but broadly constructive picture:

  • Revenue of $183.7M establishes a solid top-line base for the quarter.
  • Operating income of $31.4M implies an operating margin of approximately 17%, indicating meaningful profitability at the operating level.
  • Net income of $12.2M narrows considerably from operating income, pointing to notable below-the-line costs — interest expense, taxes, or other items — that investors should scrutinize in the full financial statements attached under Item 9.01.
  • Diluted EPS of $0.52 versus basic EPS of $1.87 represents a very wide gap, which typically signals a large number of dilutive instruments (options, warrants, convertible notes) in the capital structure. This dilution dynamic is a key factor for shareholders evaluating per-share value.
  • The stock is trading at $44.48, up 4.42% on the day, suggesting the market is responding positively to these disclosures. Notably, the current price sits meaningfully above the $38.00 price target established in StockWatch's initiating coverage published September 9, 2026.

Analysis

The Q2 FY2026 results show a business generating real revenue and operating profit, but the story beneath the surface warrants careful attention. The sharp divergence between basic EPS ($1.87) and diluted EPS ($0.52) is one of the most striking features of this filing — a gap of this magnitude typically reflects a heavily diluted share structure, and investors should examine the weighted average share counts underlying each figure to understand the true dilution exposure.

The compression from operating income ($31.4M) to net income ($12.2M) — a drop of roughly $19M — also raises questions about the company's cost of debt and tax posture. Until the full income statement and notes are reviewed, it is difficult to determine whether these below-the-line charges are structural or episodic.

The positive market reaction (+4.42%) suggests that, at face value, the revenue and profitability figures have exceeded near-term expectations. What to watch next: management's commentary on revenue trajectory, any guidance update, and a detailed breakdown of the share structure that explains the EPS divergence. The latter, in particular, could meaningfully affect how the market values earnings on a per-share basis going forward.

Disclaimer

This report is a news and informational summary prepared for general informational purposes only. It is based solely on data contained in or referenced by the SEC filing described above. It does not constitute investment advice, a solicitation, or an offer to buy or sell any security. Readers should conduct their own due diligence and consult a qualified financial adviser before making any investment decisions. StockWatch and its affiliates do not guarantee the accuracy or completeness of third-party filings or XBRL data.

Existing Coverage

StockWatch has full coverage on LIFE, published 2026-09-09. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-11-02. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/1788451/000119312526443655/life-20261102.htm

StockWatch initiated coverage · September 9, 2026

LIFE: Ethos Technologies — Pioneering the Next Generation of Biocomputing Platforms

Explosive Revenue Growth: Ethos Technologies has delivered a 340% year-over-year revenue increase in its most recent quarter, reaching $48.2M, driven by early commercial adoption of its flagship biocomputing platform. The company has transitioned from pure R&D to a commercial entity, with 14 enterprise customers now under contract. Significant R&D Investment: The company invested $312M in research and development over the past twelve months, representing 78% of total operating expens

+10.0%

Read the full report →

+10.0%

Key Data

Last

$44.48

P&L ($)

+$1.88

P&L (%)

+4.42%

Day Range

$42.50 - $49.98

Volume

569.42K

Market Cap

$2.8B

Previous Close

$42.60

Open

$49.98

52 Week Range

$9.45 - $49.98

Shares Outstanding

41.71M

Public Float

29.80M

Average Volume

1.60M

As of November 3, 2026, 9:46 AM ET

Advertise here
Stockwatch Reports

Free stock market updates, top gainers & losers, and AI-generated stock analyses — updated daily. Real-time price movements, quotes, and coverage for German & U.S. stoc